The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 07, 2019

Filed:

Sep. 01, 2015
Applicant:

Wellesley Pharmaceuticals, Llc, Newtown, PA (US);

Inventor:

David A. Dill, Newtown, PA (US);

Assignee:

WELLESLEY PHARMACEUTICALS, LLC, Newtown, PA (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 9/50 (2006.01); A61K 47/32 (2006.01); A61K 47/46 (2006.01); A61K 9/20 (2006.01); A61K 31/167 (2006.01); A61K 31/616 (2006.01); A61K 31/192 (2006.01); A61K 31/405 (2006.01); A61K 31/12 (2006.01); A61K 47/38 (2006.01); A61K 45/06 (2006.01); A61K 9/00 (2006.01); A61K 9/28 (2006.01); A61K 9/48 (2006.01); A61K 31/19 (2006.01); A61K 31/216 (2006.01); A61K 31/4025 (2006.01); A61K 31/439 (2006.01); A61K 31/4709 (2006.01); A61K 31/60 (2006.01); A61K 31/618 (2006.01);
U.S. Cl.
CPC ...
A61K 9/5084 (2013.01); A61K 9/0004 (2013.01); A61K 9/288 (2013.01); A61K 9/2846 (2013.01); A61K 9/2866 (2013.01); A61K 9/4891 (2013.01); A61K 9/5073 (2013.01); A61K 31/12 (2013.01); A61K 31/167 (2013.01); A61K 31/19 (2013.01); A61K 31/192 (2013.01); A61K 31/216 (2013.01); A61K 31/405 (2013.01); A61K 31/4025 (2013.01); A61K 31/439 (2013.01); A61K 31/4709 (2013.01); A61K 31/60 (2013.01); A61K 31/616 (2013.01); A61K 31/618 (2013.01); A61K 45/06 (2013.01); A61K 9/2081 (2013.01); A61K 9/4808 (2013.01); A61K 9/5015 (2013.01); A61K 9/5026 (2013.01); A61K 9/5031 (2013.01); A61K 9/5042 (2013.01);
Abstract

Compositions for reducing the frequency of urination and methods of manufacture of the compositions are disclosed. One method of manufacture include the steps of forming a first mixture comprising a first active ingredient comprising one or more analgesic, coating the first mixture with a first delayed-release coating to form a first component, forming a second mixture comprising a second active ingredient comprising one or more analgesic agents, coating the second mixture with a second delayed-release coating to form a second component, and combining the first component with the second component to form a third mixture.


Find Patent Forward Citations

Loading…